about
DNA methylation profiling of ovarian carcinomas and their in vitro models identifies HOXA9, HOXB5, SCGB3A1, and CRABP1 as novel targetsSurgical cytoreduction for recurrent epithelial ovarian cancerSurgical cytoreduction for recurrent epithelial ovarian cancerCytoreductive surgery plus chemotherapy versus chemotherapy alone for recurrent epithelial ovarian cancerSurgical cytoreduction for recurrent epithelial ovarian cancerSurgical debulking for recurrent epithelial ovarian cancerPredictive value of symptoms for early detection of ovarian cancerBeyond CA125: the coming of age of ovarian cancer biomarkersTargeting Stromal-Cancer Cell Crosstalk Networks in Ovarian Cancer TreatmentBreast cancer metastasising to the pelvis and abdomen: what the gynaecologist needs to know.Dairy, calcium, vitamin D and ovarian cancer risk in African-American women.Dietary carbohydrate intake, glycaemic load, glycaemic index and ovarian cancer risk in African-American women.Assessing the in vivo efficacy of doxorubicin loaded hyaluronan nanoparticles.Mass spectrometry-based clinical proteomics.Delays in the diagnosis of six cancers: analysis of data from the National Survey of NHS Patients: CancerDetermining the date of diagnosis--is it a simple matter? The impact of different approaches to dating diagnosis on estimates of delayed care for ovarian cancer in UK primary care.Identification of ovarian cancer symptoms in health insurance claims dataA hospital-based case-control study of identifying ovarian cancer using symptom index.The biology of ovarian cancer: new opportunities for translation99mTc-radiolabeled GE11-modified peptide for ovarian tumor targeting.Use of a Symptom Index, CA125, and HE4 to predict ovarian cancer.Fabrication and functional characterization of goldnanoconjugates for potential application in ovarian cancer.Oncogenic Fli-1 is a potential prognostic marker for the progression of epithelial ovarian cancer.Effect of delays in primary care referral on survival of women with epithelial ovarian cancer: retrospective audit.Proteomics and ovarian cancer: integrating proteomics information into clinical careSymptom presentation in invasive ovarian carcinoma by tumor histological type and grade in a multiethnic population: a case analysisDown-regulated miR-22 as predictive biomarkers for prognosis of epithelial ovarian cancer.Somatic mutations favorable to patient survival are predominant in ovarian carcinomasHistone h1.3 suppresses h19 noncoding RNA expression and cell growth of ovarian cancer cellsEstimating the workload associated with symptoms-based ovarian cancer screening in primary care: an audit of electronic medical recordsRisk factors for ovarian cancer: an overview with emphasis on hormonal factors.A novel targeted therapy of Leydig and granulosa cell tumors through the luteinizing hormone receptor using a hecate-chorionic gonadotropin beta conjugate in transgenic mice.Identifying symptoms of ovarian cancer: a qualitative and quantitative studyOvarian cyst fluids are a cache of tumor biomarkers that include calgranulin A and calgranulin B isoforms.Ovarian cancer symptom awareness and anticipated delayed presentation in a population sample.Immunotherapeutic approaches to ovarian cancer treatment.Design and Implementation of a Comprehensive Web-based Survey for Ovarian Cancer Survivorship with an Analysis of Prediagnosis Symptoms via Text Mining.The functional proteomics analysis of VEGF-treated human epithelial ovarian cancer cells.Targeted ovarian cancer treatment: the TRAILs of resistance.Symptom triggered screening for ovarian cancer: a pilot study of feasibility and acceptability
P2860
Q21245727-04F475FD-B63B-4196-AE0E-BD871FECF166Q24200882-F8D98D38-1EBB-4BC7-8536-43362FFD979CQ24204014-A2A25D75-9F55-44C5-9C22-A658612C57BFQ24234736-8C29A138-FBD5-40EB-8772-3BDD588EB66CQ24235192-B0DA3C0F-78E5-4748-B097-4837CB744BF8Q24240236-D3338DEF-23C5-46A7-A312-951C7FFE1E2CQ24644590-D6FA739A-5049-4702-9815-7773CEC4818EQ24651567-BAD92D35-8DBB-41FE-A42F-7406C2C75475Q26769963-D80B67B6-7EDE-4938-B6DD-76F5D040FB87Q27687062-76C850A6-9DE2-4EBA-B3E8-58D51AF421D5Q30275624-D6D737E7-AE94-41F1-8983-FD24E9220165Q30353949-A91B7B2D-617E-496B-B5F9-1D4C3C078BECQ30570691-55113E97-ADE3-4FBD-814D-6BBA4504711BQ30954345-F9D0B330-E9F5-476E-B4EE-B1F637CA94A2Q30988858-F4673F40-D49C-4F74-9087-E4F4156FFF98Q33473014-F63F8B5E-4F0D-4BC4-840E-C9839AC28503Q33531314-6DA6BF6E-A7A4-4048-8746-04E4BB334F6CQ33561005-0B85BB3D-7EE9-4D5F-9D07-5B16EF218684Q33622369-75EA22F5-D953-47AD-9001-9A360FCA7C19Q33630303-E09E29D6-067E-4A02-9477-EE8FBEA88F59Q33653799-C520F0FB-971B-4785-9486-CC4B54FDE19EQ33812669-D3DBE477-2B8E-4037-9D9B-53C8CEF750AAQ33873793-0F89BB86-3352-4593-8186-58A2C80EB515Q33951578-0EC7B256-B181-46F1-88EF-59238A61B781Q34126627-3F2B126D-EC0F-4CD1-9D6E-42B1A949D9B4Q34173704-D5B4634B-02D9-4CDF-9006-9A036484E134Q34268397-ABA29E6E-045C-487D-84BB-4B16B03C0E57Q34497796-96600E3C-F5C7-41D3-A281-5E64494555E2Q34518349-3BDB9D91-3DDD-4ADD-9493-10F3D3B35117Q34740050-7F101DB5-8397-4D00-8FEB-6CBA438331E7Q34764768-002E8CE8-8A9A-4810-9D87-E1563C9534E5Q34768470-3AC2E18B-7575-47F3-B6DB-EA57660C9EEBQ34800099-2E30811F-840D-4875-9E3F-6340E9E9ED25Q34893763-A3FDD5CD-3E81-43E7-9469-F46A90E7A056Q35115543-F4B571C2-AFEB-442F-A6E4-CAF5BFBD4D25Q35213535-59288FC5-DA78-4508-B290-0C33FC57B891Q35216998-1DCE28C1-15C4-4D4E-AE38-142C5D2A57DAQ35240167-389BD43F-F559-4056-B0A8-E6D1090DBBCCQ35609438-E72CCD5B-BA0C-4C4C-B680-3AAB38786FB6Q35690554-F8714543-25B1-47A6-8676-1F95ECA9C6EF
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Ovarian carcinoma diagnosis.
@ast
Ovarian carcinoma diagnosis.
@en
Ovarian carcinoma diagnosis.
@nl
type
label
Ovarian carcinoma diagnosis.
@ast
Ovarian carcinoma diagnosis.
@en
Ovarian carcinoma diagnosis.
@nl
prefLabel
Ovarian carcinoma diagnosis.
@ast
Ovarian carcinoma diagnosis.
@en
Ovarian carcinoma diagnosis.
@nl
P2093
P2860
P1433
P1476
Ovarian carcinoma diagnosis.
@en
P2093
P2860
P304
P356
10.1002/1097-0142(20001115)89:10<2068::AID-CNCR6>3.0.CO;2-Z
P407
P577
2000-11-01T00:00:00Z